Nature retracted a high-profile paper that served as part of the scientific groundwork for Micronoma, a San Diego-based startup, on Wednesday.
“Some of the findings of the article are affected and the corresponding conclusions are no longer supported,” Nature said in the retraction.
The retraction comes after a team of researchers published work on the preprint site bioRxiv critiquing the Nature paper last August, describing what they called “fatal errors” in the paper’s analyses. STAT covered the criticism shortly after the team’s manuscript went live on bioRxiv. This same work was later published in the peer-reviewed journal mBio.
